Back
Bicara Therapeutics Vs. AAR Industry Stock Comparison
Sell
1
BCAX
Bicara Therapeutics
Last Price:
$10.56
Seasonality Move:
--
Sell
18
AIR
AAR
Last Price:
$50.12
Seasonality Move:
5.57%
Sell
1
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $10.57. The Score for BCAX is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $10.57Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.
AIR Stock Price Chart
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 35.09 | Sell |
Chaikin Money Flow: | -482112 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.14 - 14.48) | Sell |
Bollinger Bands (100): | (12.09 - 19.17) | Sell |
AIR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.13 | Sell |
Relative Strength Index (14 RSI): | 23.35 | Sell |
Chaikin Money Flow: | -101237 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (58.35 - 69.35) | Sell |
Bollinger Bands (100): | (61.64 - 69.74) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.66 | Sell |
20-day SMA: | 13.13 | Sell |
50-day SMA: | 12.95 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 12.34 | Sell |
20-day EMA: | 12.87 | Sell |
50-day EMA: | 13.48 | Sell |
200-day EMA: | 11.37 | Sell |
AIR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.48 | Sell |
20-day SMA: | 63.86 | Sell |
50-day SMA: | 65.45 | Sell |
200-day SMA: | 65.61 | Sell |
8-day EMA: | 57.27 | Sell |
20-day EMA: | 61.62 | Sell |
50-day EMA: | 64.1 | Sell |
200-day EMA: | 64.99 | Sell |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
AAR Earnings Growth & AIR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.04 per share, an increase this year of $0.46 per share, and an increase next year of $0.73 per share.
Bicara Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AAR Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |